Voyager Therapeutics (VYGR) EBIT Growth (3y) (2017 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) EBIT Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 52.34% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 22.17% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | -29.43% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 28.05% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 27.50% |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | -1.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.25% |
| Mar 31, 2026 | -30.97% |
| Dec 31, 2025 | -6.81% |
| Sep 30, 2025 | -60.29% |
| Jun 30, 2025 | -23.66% |
| Mar 31, 2025 | -17.57% |
| Dec 31, 2024 | -105.80% |
| Sep 30, 2024 | 18.17% |
| Jun 30, 2024 | 19.30% |
| Mar 31, 2024 | 14.16% |
| Dec 31, 2023 | 62.34% |
| Sep 30, 2023 | -32.93% |
| Jun 30, 2023 | -41.47% |
| Mar 31, 2023 | 91.56% |
| Dec 31, 2022 | -21.28% |
| Sep 30, 2022 | 41.13% |
| Jun 30, 2022 | -60.15% |
| Mar 31, 2022 | 10.01% |
| Dec 31, 2021 | 30.96% |
| Sep 30, 2021 | -5.94% |